Stay updated on Elotuzumab Combinations in Relapsed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elotuzumab Combinations in Relapsed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elotuzumab Combinations in Relapsed Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page history shows a new revision, v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T02:06:47.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the history.
    Difference
    0.1%
    Check dated 2026-03-25T07:17:39.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 has been added to the history. The previous revision v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-10T15:00:53.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2 in the page history, with no changes to the study record content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-17T04:00:24.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 to the history. Removed the notices for funding lapse and Revision: v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-10T01:11:45.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added a site-wide notice at the top about a lapse in government funding and NIH operating status, with links to cc.nih.gov and opm.gov. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-02T21:45:47.000Z thumbnail image

Stay in the know with updates to Elotuzumab Combinations in Relapsed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elotuzumab Combinations in Relapsed Multiple Myeloma Clinical Trial page.